跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bacillus Coagulans
首页
药物
Bacillus Coagulans
Bacillus Coagulans
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US 7767203 B2
申请人: GANEDEN BIOTECH INC
优先权: 2004
US
13 件公开
Pharmaceutical composition comprising a Pseudomonas lindbergii supernatant and a Bacillus coagulans supernatant and its use
EP 1632239 A1
申请人: GANEDEN BIOTECH INC
优先权: 1999
EP
US
WO
11 件公开
BEVERAGE COMPOSITIONS CONTAINING BACILLUS COAGULANS MTCC 5856
EP 3638275 A4
申请人: SAMI LABS LTD
优先权: 2017
EP
US
WO
6 件公开
BACILLUS COAGULANS HAVING BLOOD GLUCOSE REDUCTION EFFICACY, AND APPLICATION THEREOF
EP 4223867 A4
申请人: QINGDAO VLAND BIOTECH INC
优先权: 2020
CN
EP
US
WO
5 件公开
Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
US 7232571 B2
申请人: GANEDEN BIOTECH INC
优先权: 2001
US
5 件公开
DIRECT-FED MICROBIALS USING B. COAGULANS
EP 4598370 A2
申请人: MICROBIAL DISCOVERY GROUP LLC
优先权: 2022
CN
EP
US
WO
4 件公开
MODULATION OF IMMUNE FUNCTION BY BACILLUS COAGULANS
EP 3787651 A4
申请人: SAMI LABS LTD
优先权: 2018
EP
US
WO
4 件公开
Absorbent product containing absorbent structure and bacillus coagulans
US 7025974 B2
申请人: GANEDEN BIOTECH INC
优先权: 2004
US
4 件公开
Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof
US 9596861 B2
申请人: MAJEED MUHAMMED
优先权: 2014
US
4 件公开
SKIN CARE APPLICATIONS OF EXTRACELLULAR METABOLITES FROM BACILLUS COAGULANS
EP 3634441 B1
申请人: SAMI SABINSA GROUP LTD
优先权: 2017
CN
EP
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈